• Home>
  • Stocks>
  • Nath Bio-Genes (India) Ltd Share Price
Nath Bio-Genes (India) Ltd share price logo

Nath Bio-Genes (India) Ltd Share Price

(NATHBIOGEN)

₹145.851.23%

as on 04:01PM, 28 Mar 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Nath Bio-Genes (India) Ltd Performance

  • Day's Low

    Day's High

    ₹145
    Day's Price Range
    ₹151
  • 52 Week's Low

    52 Week's High

    ₹137.55
    52-Week Price Range
    ₹264.31
1 Month Return+ 1.19 %
3 Month Return-21.82 %
1 Year Return-19.82 %
Previous Close₹147.67
Open₹147.91
Volume52.68K
Upper Circuit₹177.20
Lower Circuit₹118.13
Market Cap₹277.17Cr

Nath Bio-Genes (India) Ltd Fundamentals

P/E Ratio

6.87

PEG Ratio

-343.66

Market Cap

₹277.17 Cr

P/B Ratio

0.54

EPS

20.85

Dividend Yield

1.15

Sector

FMCG

ROE

6.79

Mutual Fund Holdings of Nath Bio-Genes (India) Ltd

Key events for Nath Bio-Genes (India) Ltd

  • Positive Buying Interest in Nath Bio-Genes Stock - 27 Feb, 2025

    Nath Bio-Genes (India) Ltd shows potential for revival with steady buying interest at lower levels. Recommended buy at ₹161, targeting ₹171 with a stop at ₹156.

Insights on Nath Bio-Genes (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.18% to 0.19% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 1.11 Cr → 2.65 Cr (in ₹), with an average increase of 58.1% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 32.27 Cr → 37.35 Cr (in ₹), with an average increase of 13.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Kaveri Seed Company Ltd has given 94.7% return, outperforming this stock by 114.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Kaveri Seed Company Ltd has given 134.2% return, outperforming this stock by 166.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 45.60% of holdings in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 49.85% to 49.84% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, NATHBIOGEN stock has moved down by -11.8%

Nath Bio-Genes (India) Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹31.74Cr (-)₹43.04Cr (↑35.60%)₹243.88Cr (↑466.64%)₹32.19Cr (↓86.80%)₹36.87Cr (↑14.54%)
Net Income₹3.82Cr (-)₹2.62Cr (↓31.41%)₹33.35Cr (↑1,172.90%)₹1.11Cr (↓96.67%)₹2.65Cr (↑138.74%)
Net Profit Margin12.04% (-)6.09% (↓49.42%)13.67% (↑124.47%)3.45% (↓74.76%)7.19% (↑108.41%)
Value in ₹ crore
Details2021202220232024
Total Assets₹789.52Cr (-)₹739.54Cr (↓6.33%)₹792.97Cr (↑7.22%)₹877.08Cr (↑10.61%)
Total Liabilities₹176.25Cr (-)₹197.57Cr (↑12.10%)₹219.62Cr (↑11.16%)₹266.43Cr (↑21.31%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹9.48Cr (-)₹1.11Cr (↓88.29%)₹17.05Cr (↑1,436.04%)₹38.37Cr (↑125.04%)₹74.72Cr (↑94.74%)

Nath Bio-Genes (India) Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
45.6%
0.00
Foreign Institutions
0.19%
1.73
Mutual Funds
4.37%
0.00
Retail Investors
49.84%
-0.01
Others
0%
-3.23

Nath Bio-Genes (India) Ltd Key Indicators

Details20202021202220232024
Return On Equity %9.489.514.126.316.79
Details20232024
Return On Assets %4.424.52
Details202220232024
Book Value Per Share (₹)285.16301.61320.94
Details202220232024
Earning Per Share (₹)-35.4618.4220.85

Nath Bio-Genes (India) Ltd Valuation

Nath Bio-Genes (India) Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-3.78x)

January 3, 2023

Today (6.87x)

March 28, 2025

Industry (54.97x)

March 28, 2025

Highest (11.85x)

August 4, 2023

LowHigh

Nath Bio-Genes (India) Ltd Earnings and Dividends

  • Nath Bio-Genes (India) Ltd Earnings Results

    Nath Bio-Genes (India) Ltd’s net profit fell -30.81% since last year same period to ₹2.65Cr in the Q3 2024-2025. On a quarterly growth basis, Nath Bio-Genes (India) Ltd has generated 138.74% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Nath Bio-Genes (India) Ltd Dividends May,2024

    In the quarter ending March 2024, Nath Bio-Genes (India) Ltd has declared dividend of ₹2 - translating a dividend yield of 1.37%.

    Read More about Dividends

Nath Bio-Genes (India) Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Nath Bio-Genes (India) Ltd is currently in a Bearish trading position according to technical analysis indicators.

Nath Bio-Genes (India) Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹277.17 Cr1.56%0.58₹39 Cr₹332 Cr
NA₹72.95 Cr158.26%0.64NANA
NA₹154.61 Cr-6.3%0.71₹7 Cr₹436 Cr
NA₹106.47 Cr43.96%0.63-₹5 Cr₹269 Cr
NA₹28.05 Cr77.4%0.85NANA

About Nath Bio-Genes (India) Ltd

Nath BioGenes India Limited was established in 1993, as a private limited company, to produce, process and market hybrid and GM seeds. With 16 business centers spanning 131 territories across India, it has an extensive network of 2000 distributors, enabling it to cater to PAN India and far abroad markets in Asia, Africa and the Middle East. To improve the quality of its production, the company has incorporated modern infrastructure facilities, biotech and seed technology labs. Their range of field crop, vegetable crop and plant nutrient supplements have enabled it to gain various prestigious awards, such as the Vasantrao Naik Prathisthan Award, for its contribution towards enhancing agricultural productivity. It has also collaborated with major International and National Centres of Excellence, such as the NRCPB, CIMMYT, IRRI, and ICRISAT. The company has set rigorous field standards, quality control checks, and elaborate seed processing facilities, to ensure that only seeds of the highest quality reaches customers. Its 3-phase trial system with 40 testing locations, 8 centres, and all agroclimatic zones of India, has enabled it to rigorously test products and compare yields with competitor products. This comprehensive system has allowed Nath BioGenes India Limited to be a successful hybrid and GM seed provider in India and internationally.

Revenue: ₹36.87Cr as on December 2024 (Q4 24)
Net Profit: ₹2.65Cr as on December 2024 (Q4 24)
Listing date: 28 Jan, 2014
OrganisationNath Bio-Genes (India) Ltd
Headquarters
IndustryFMCG
E-voting on sharesClick here to vote

FAQs on Nath Bio-Genes (India) Ltd

What is Nath Bio-Genes (India) Ltd price today?

Nath Bio-Genes (India) Ltd share price today stands at ₹145.85, Open: ₹147.91, Previous Close: ₹147.67, High: ₹151, Low: ₹145, 52 Week High: ₹264.31, 52 Week Low: ₹137.55.

How to Buy Nath Bio-Genes (India) Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Nath Bio-Genes (India) Ltd shares

What are today's traded volumes of Nath Bio-Genes (India) Ltd?

Today's traded volume of Nath Bio-Genes (India) Ltd(NATHBIOGEN) is 52.68K.

What is today's market capitalisation of Nath Bio-Genes (India) Ltd?

Today's market capitalisation of Nath Bio-Genes (India) Ltd(NATHBIOGEN) is ₹277.17Cr.

What is the 52 Week High and Low Range of Nath Bio-Genes (India) Ltd?

Nath Bio-Genes (India) Ltd (NATHBIOGEN)
Price
52 Week High
₹264.31
52 Week Low
₹137.55

How much percentage Nath Bio-Genes (India) Ltd is down from its 52 Week High?

Nath Bio-Genes (India) Ltd (NATHBIOGEN) share price is ₹145.85. It is down -44.82% from its 52 Week High price of ₹264.31

How much percentage Nath Bio-Genes (India) Ltd is up from its 52 Week low?

Nath Bio-Genes (India) Ltd (NATHBIOGEN) share price is ₹145.85. It is up 6.03% from its 52 Week Low price of ₹137.55